3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Sarcoma
1
Rare Diseases
1
Neuroblastoma
1
Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Genetic Predisposition to Disease
1
Breast Neoplasms
1
Interventions
Metformin
2
Leuprolide
2
Collagenases
2
Clomiphene
2
tremelimumab
1
durvalumab
1
Temozolomide
1
Streptozocin
1
Spironolactone
1
Specimen Handling
1
Radiosurgery
1
Radiation
1
Propofol
1
Prednisone
1
Plasma Exchange
1
Nivolumab
1
Midazolam
1
Mercaptopurine
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Irinotecan
1
Ipilimumab
1
Infliximab
1
Immunoglobulins
1
High-Throughput Nucleotide Sequencing
1
Fentanyl
1
FANG vaccine
1
Cyclophosphamide
1
Clomipramine
1
Carmustine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Rare Diseases
×
High-Throughput Nucleotide Sequencing
×
Clear all
NCT06060184
2023-09-29
IonGER
University Hospital Tuebingen
Phase NA
Not yet recruiting
500 enrolled